RELAPSED MANTLE CELL LYMPHOMA

Clinical trials for RELAPSED MANTLE CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new RELAPSED MANTLE CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for RELAPSED MANTLE CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for lymphoma patients who stop responding to standard drugs

Disease control Recruiting now

This study is testing whether adding a targeted drug called loncastuximab tesirine after a short course of chemotherapy can help control relapsed mantle cell lymphoma in patients whose cancer stopped responding to or who couldn't tolerate BTKi drugs. About 49 patients will receiv…

Matched conditions: RELAPSED MANTLE CELL LYMPHOMA

Phase: PHASE2 • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control

Last updated Mar 02, 2026 15:26 UTC

RELAPSED MANTLE CELL LYMPHOMA

Get alerted when new RELAPSED MANTLE CELL LYMPHOMA trials appear

New hope for lymphoma patients who stop responding to standard drugs